This biotech is working on a GLP-1 pill that could be better than the Wegovy version
This experimental pill helped people lose about 16% of their body weight after about a year of treatment
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
JPMorgan beat earnings expectations amid record market revenue, but a downbeat outlook for net interest income hurt the stock.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesThis experimental pill helped people lose about 16% of their body weight after about a year of treatment
Novo Nordisk slump wipes out last Wegovy-era gains after trial setback
'It's not an easy pill to take': The first highly anticipated GLP-1 pill is here, but physicians aren't sure it has the staying power of the injections
Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk's Wegovy ora...
The Bitcoin rout continues, one IPO pauses while three more move ahead, Hims & Hers offers knockoff Wegovy pill, and more news to start your day.
Novo's Wegovy pill makes 'encouraging' start in weight-loss race vs Lilly
UK regulator approves 7.2 mg Wegovy dose for obesity; Novo Nordisk shares up 3%
Novo launches Wegovy weight-loss pill for sale in US
Novo Nordisk's wildly successful obesity medicine is now available as a pill, making it the first GLP-1 pill for weight loss in the U.S.
Novo's Wegovy pill to test demand from consumers with cash
Here's how the next generation of obesity drugs getting closer to patients differs from Wegovy and Zepbound
Eli Lilly and Novo Nordisk file their new weight-loss drugs with the FDA.